Cancer, COVID-19, and antiviral immunity: The CAPTURE study


The SARS-CoV-2 pandemic has posed a significant challenge for risk evaluation and mitigation among cancer patients. Susceptibility to and severity of COVID-19 in cancer patients has not been studied in a prospective and broadly applicable manner. CAPTURE is a pan-cancer, longitudinal immune profiling study designed to address this knowledge gap.

Journal details

Journal Cell
Volume 183
Issue number 1
Pages 4-10
Available online
Publication date